Jianping Zeng

Showing 1-7 of 7 articles

Other

Prewire channel stent: a novel stent for bifurcation lesions in a pig model

Tang L, Lu G, Feng J, Zhang W, Zeng Y

February 2, 2018 | 10.4244/EIJ-D-17-00513

Coronary interventions

Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study

Suwannasom P, Sotomi Y, Asano T, Koon J, Tateishi H, Zeng Y, Tenekecioglu E, Wykrzykowska J, Foin N, de Winter R, Ormiston J, Serruys PW, Onuma Y

April 7, 2017 | 10.4244/EIJ-D-16-00740

Coronary interventions

Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial

Cavalcante R, Onuma Y, Sotomi Y, Collet C, Thomsen B, Rogers C, Zeng Y, Tenekecioglu E, Asano T, Miyazaki Y, Abdelghani M, Morel M, Serruys PW

March 20, 2017 | 10.4244/EIJ-D-16-00612

Coronary interventions

Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up

Nakatani S, Sotomi Y, Ishibashi Y, Grundeken M.J, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Regar E, Radu M, Räber L, Bezerra H, Costa M, Fitzgerald P, Prati F, Costa R, Dijkstra J, Kimura T, Kozuma K, Tanabe K, Akasaka T, Di Mario C, Serruys PW, Onuma Y

December 20, 2016 | 10.4244/EIJY15M10_03

Coronary interventions

Preclinical assessment of the endothelial shear stress in porcine-based models following implantation of two different bioresorbable scaffolds: effect of scaffold design on the local haemodynamic micro-environment

Tenekecioglu E, Torii R, Bourantas C, Crake T, Zeng Y, Sotomi Y, Onuma Y, Yılmaz M, Santoso T, Serruys PW

November 20, 2016 | 10.4244/EIJY16M05_01

Coronary interventions

Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?

Sotomi Y, Onuma Y, Suwannasom P, Tateishi H, Tenekecioglu E, Zeng Y, Cavalcante R, Jonker H, Dijkstra J, Foin N, Koon J, Collet C, de Winter R, Wykrzykowska J, Stone G, Popma J, Kozuma K, Tanabe K, Serruys PW, Kimura T

October 10, 2016 | 10.4244/EIJV12I8A163

Interventions for valvular disease

The Sino Medical AccuFit transcatheter mitral valve implantation system

Abdelghani M, Onuma Y, Zeng Y, Soliman O, Ma J, Huo Y, Guidotti A, Nietlispach F, Maisano F, Serruys PW

September 17, 2015 | 10.4244/EIJV11SWA26

1

Latest news

State-of-the-Art on Coronary Physiology; a Mini Focus on Biostatistics; Post-TAVI Aortic Manipulation; Minimally Invasive Ventricular Reconstruction after MI

EBC 15th consensus document

Save the date: 19th April at 6pm (CET). Join us on Twitter for the 2nd edition

This Week's JAA's: Deep Learning Model to Detect AMI, Mortality After Bleeding vs MI in CAD Patients...

New update: EXAMINATION 10 years, BIONYX 2 years, SAFE A, MASH and more

(Thanks to the support of Biotronik)

Randomised Comparison between POT and KBT: PROPOT Trial

Yusuke Watanabe et al.

Similar long-term outcome of dissimilar drug-eluting stents: is it time to change the assessment?

Clemens von Birgelen et al.

Optimising Physiological Endpoints of Percutaneous Coronary Intervention

Valvular disease